Cargando…

Clinical Profile of SARS-CoV-2 Infection: Mechanisms of the Cellular Immune Response and Immunogenetic Markers in Patients from Brazil

Objectives: The aim of this study is to evaluate some mechanisms of the immune response of people infected with SARS-CoV-2 in both acute infection and early and late convalescence phases. Methods: This is a cohort study of 70 cases of COVID-19, confirmed by RT-PCR, followed up to 60 days. Plasma Sam...

Descripción completa

Detalles Bibliográficos
Autores principales: Pacheco, Vanessa, Cuber Guimarães, Rosane, Corrêa-Moreira, Danielly, Magalhães, Carlos Eduardo, Figueiredo, Douglas, Guttmann, Patricia, Trindade, Gisela Freitas, da Silva, Juliana Fernandes Amorim, Ano Bom, Ana Paula Dinis, de Lourdes Maia, Maria, Melgaço, Juliana Gil, da Costa Barros, Tamiris Azamor, da Silva, Andrea Marques Vieira, Oliveira, Manoel Marques Evangelista
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385121/
https://www.ncbi.nlm.nih.gov/pubmed/37515295
http://dx.doi.org/10.3390/v15071609
_version_ 1785081325403766784
author Pacheco, Vanessa
Cuber Guimarães, Rosane
Corrêa-Moreira, Danielly
Magalhães, Carlos Eduardo
Figueiredo, Douglas
Guttmann, Patricia
Trindade, Gisela Freitas
da Silva, Juliana Fernandes Amorim
Ano Bom, Ana Paula Dinis
de Lourdes Maia, Maria
Melgaço, Juliana Gil
da Costa Barros, Tamiris Azamor
da Silva, Andrea Marques Vieira
Oliveira, Manoel Marques Evangelista
author_facet Pacheco, Vanessa
Cuber Guimarães, Rosane
Corrêa-Moreira, Danielly
Magalhães, Carlos Eduardo
Figueiredo, Douglas
Guttmann, Patricia
Trindade, Gisela Freitas
da Silva, Juliana Fernandes Amorim
Ano Bom, Ana Paula Dinis
de Lourdes Maia, Maria
Melgaço, Juliana Gil
da Costa Barros, Tamiris Azamor
da Silva, Andrea Marques Vieira
Oliveira, Manoel Marques Evangelista
author_sort Pacheco, Vanessa
collection PubMed
description Objectives: The aim of this study is to evaluate some mechanisms of the immune response of people infected with SARS-CoV-2 in both acute infection and early and late convalescence phases. Methods: This is a cohort study of 70 cases of COVID-19, confirmed by RT-PCR, followed up to 60 days. Plasma Samples and clinical data were. Viral load, blood count, indicators inflammation were the parameters evaluated. Cellular immune response was evaluated by flow cytometry and Luminex immunoassays. Results: In the severe group, hypertension was the only reported comorbidity. Non severe patients have activated memory naive CD4+ T cells. Critically ill patients have central memory CD4+ T cell activation. Severe COVID-19 patients have both central memory and activated effector CD8+ T cells. Non-severe COVID-19 cases showed an increase in IL1β, IL-6, IL-10 and TNF and severely ill patients had higher levels of the cytokines IL-6, IL-10 and CXCL8. Conclusions: The present work showed that different cellular responses are observed according to the COVID-19 severity in patients from Brazil an epicenter the pandemic in South America. Also, we notice that some cytokines can be used as predictive markers for the disease outcome, possibility implementation of strategies effective by health managers.
format Online
Article
Text
id pubmed-10385121
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-103851212023-07-30 Clinical Profile of SARS-CoV-2 Infection: Mechanisms of the Cellular Immune Response and Immunogenetic Markers in Patients from Brazil Pacheco, Vanessa Cuber Guimarães, Rosane Corrêa-Moreira, Danielly Magalhães, Carlos Eduardo Figueiredo, Douglas Guttmann, Patricia Trindade, Gisela Freitas da Silva, Juliana Fernandes Amorim Ano Bom, Ana Paula Dinis de Lourdes Maia, Maria Melgaço, Juliana Gil da Costa Barros, Tamiris Azamor da Silva, Andrea Marques Vieira Oliveira, Manoel Marques Evangelista Viruses Article Objectives: The aim of this study is to evaluate some mechanisms of the immune response of people infected with SARS-CoV-2 in both acute infection and early and late convalescence phases. Methods: This is a cohort study of 70 cases of COVID-19, confirmed by RT-PCR, followed up to 60 days. Plasma Samples and clinical data were. Viral load, blood count, indicators inflammation were the parameters evaluated. Cellular immune response was evaluated by flow cytometry and Luminex immunoassays. Results: In the severe group, hypertension was the only reported comorbidity. Non severe patients have activated memory naive CD4+ T cells. Critically ill patients have central memory CD4+ T cell activation. Severe COVID-19 patients have both central memory and activated effector CD8+ T cells. Non-severe COVID-19 cases showed an increase in IL1β, IL-6, IL-10 and TNF and severely ill patients had higher levels of the cytokines IL-6, IL-10 and CXCL8. Conclusions: The present work showed that different cellular responses are observed according to the COVID-19 severity in patients from Brazil an epicenter the pandemic in South America. Also, we notice that some cytokines can be used as predictive markers for the disease outcome, possibility implementation of strategies effective by health managers. MDPI 2023-07-23 /pmc/articles/PMC10385121/ /pubmed/37515295 http://dx.doi.org/10.3390/v15071609 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Pacheco, Vanessa
Cuber Guimarães, Rosane
Corrêa-Moreira, Danielly
Magalhães, Carlos Eduardo
Figueiredo, Douglas
Guttmann, Patricia
Trindade, Gisela Freitas
da Silva, Juliana Fernandes Amorim
Ano Bom, Ana Paula Dinis
de Lourdes Maia, Maria
Melgaço, Juliana Gil
da Costa Barros, Tamiris Azamor
da Silva, Andrea Marques Vieira
Oliveira, Manoel Marques Evangelista
Clinical Profile of SARS-CoV-2 Infection: Mechanisms of the Cellular Immune Response and Immunogenetic Markers in Patients from Brazil
title Clinical Profile of SARS-CoV-2 Infection: Mechanisms of the Cellular Immune Response and Immunogenetic Markers in Patients from Brazil
title_full Clinical Profile of SARS-CoV-2 Infection: Mechanisms of the Cellular Immune Response and Immunogenetic Markers in Patients from Brazil
title_fullStr Clinical Profile of SARS-CoV-2 Infection: Mechanisms of the Cellular Immune Response and Immunogenetic Markers in Patients from Brazil
title_full_unstemmed Clinical Profile of SARS-CoV-2 Infection: Mechanisms of the Cellular Immune Response and Immunogenetic Markers in Patients from Brazil
title_short Clinical Profile of SARS-CoV-2 Infection: Mechanisms of the Cellular Immune Response and Immunogenetic Markers in Patients from Brazil
title_sort clinical profile of sars-cov-2 infection: mechanisms of the cellular immune response and immunogenetic markers in patients from brazil
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10385121/
https://www.ncbi.nlm.nih.gov/pubmed/37515295
http://dx.doi.org/10.3390/v15071609
work_keys_str_mv AT pachecovanessa clinicalprofileofsarscov2infectionmechanismsofthecellularimmuneresponseandimmunogeneticmarkersinpatientsfrombrazil
AT cuberguimaraesrosane clinicalprofileofsarscov2infectionmechanismsofthecellularimmuneresponseandimmunogeneticmarkersinpatientsfrombrazil
AT correamoreiradanielly clinicalprofileofsarscov2infectionmechanismsofthecellularimmuneresponseandimmunogeneticmarkersinpatientsfrombrazil
AT magalhaescarloseduardo clinicalprofileofsarscov2infectionmechanismsofthecellularimmuneresponseandimmunogeneticmarkersinpatientsfrombrazil
AT figueiredodouglas clinicalprofileofsarscov2infectionmechanismsofthecellularimmuneresponseandimmunogeneticmarkersinpatientsfrombrazil
AT guttmannpatricia clinicalprofileofsarscov2infectionmechanismsofthecellularimmuneresponseandimmunogeneticmarkersinpatientsfrombrazil
AT trindadegiselafreitas clinicalprofileofsarscov2infectionmechanismsofthecellularimmuneresponseandimmunogeneticmarkersinpatientsfrombrazil
AT dasilvajulianafernandesamorim clinicalprofileofsarscov2infectionmechanismsofthecellularimmuneresponseandimmunogeneticmarkersinpatientsfrombrazil
AT anobomanapauladinis clinicalprofileofsarscov2infectionmechanismsofthecellularimmuneresponseandimmunogeneticmarkersinpatientsfrombrazil
AT delourdesmaiamaria clinicalprofileofsarscov2infectionmechanismsofthecellularimmuneresponseandimmunogeneticmarkersinpatientsfrombrazil
AT melgacojulianagil clinicalprofileofsarscov2infectionmechanismsofthecellularimmuneresponseandimmunogeneticmarkersinpatientsfrombrazil
AT dacostabarrostamirisazamor clinicalprofileofsarscov2infectionmechanismsofthecellularimmuneresponseandimmunogeneticmarkersinpatientsfrombrazil
AT dasilvaandreamarquesvieira clinicalprofileofsarscov2infectionmechanismsofthecellularimmuneresponseandimmunogeneticmarkersinpatientsfrombrazil
AT clinicalprofileofsarscov2infectionmechanismsofthecellularimmuneresponseandimmunogeneticmarkersinpatientsfrombrazil
AT oliveiramanoelmarquesevangelista clinicalprofileofsarscov2infectionmechanismsofthecellularimmuneresponseandimmunogeneticmarkersinpatientsfrombrazil